Quality Analysis of Cyathulae Radix Based on National Drug Sampling and Testing and Some Suggestions
OBJECTIVE To analyze the quality differences of Cyathulae Radix from different manufacturers on the market based on national drug sampling and testing in 2022,then analyze the problems and put forward suggestions to provide basis for the quality supervision and standard improvement of Cyathulae Radix.METHODS Inspection was conducted according to corresponding stand-ards,inspection reports were issued,and then quality evaluation and analysis were conducted.At the same time,problems were found and suggestions were made based on targeted exploratory research on quality problems,standard problems and other related problems found in the inspection RESULTS A total of 334 batches of Cyathulae Radix samples were taken.According to the standard inspec-tion,two batches of samples were found to be substandard in character,and Cyathulae capitatae Radix was used as Cyathulae Radix.At the same time,it was found that the content determination methods in the standard were too complex,and the specified limit for con-tent determination was too low.In the exploratory study,the unique component achybidensaponin I was detected in 27 batches of Cya-thulae Radix and 7 batches exceeded the specified limit,which was mixed with Achyranthes bidentata.Plant growth regulator(paclobutrazol)was detected in 270 batches of Cyathulae capitatae Radix The detection of heavy metals and harmful elements cadmi-um(Cd)in 114 batches exceeded the limit.Finally,the quality standard of Cyathulae Radix was improved,the supplementary test method was established,and the risk warning was put forward.CONCLUSION Through the national sampling inspection,the rele-vant problems in the prepared slices and quality standards of Cyathulae Radix are found,suggesting that the quality standards should be improved and the quality supervision of Cyathulae Radix should be strengthened.
Cyathulae RadixCyathulae capitatae Radixnational drug sampling and testingquality analysispaclobutrazol